Telomir Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Telomir Pharmaceuticals has a total shareholder equity of $442.1K and total debt of $93.4K, which brings its debt-to-equity ratio to 21.1%. Its total assets and total liabilities are $1.0M and $599.9K respectively.
Key information
21.1%
Debt to equity ratio
US$93.43k
Debt
| Interest coverage ratio | n/a |
| Cash | US$834.64k |
| Equity | US$442.07k |
| Total liabilities | US$599.91k |
| Total assets | US$1.04m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: TELO's short term assets ($1.0M) exceed its short term liabilities ($599.9K).
Long Term Liabilities: TELO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TELO has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TELO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TELO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TELO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 86.2% each year